Early Access

10-QPeriod: Q1 FY2020

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2020

Filed April 30, 2020For Securities:AFL

Summary

Aflac Incorporated reported net earnings of $566 million for the first quarter of 2020, a decrease from $928 million in the prior year, primarily due to a significant increase in net investment losses. Total revenues declined to $5.2 billion from $5.7 billion year-over-year. The company experienced a substantial unrealized loss on its fixed maturity securities, contributing to a significant drop in total comprehensive income. Despite market volatility and the ongoing impact of COVID-19, Aflac Japan's pretax adjusted earnings increased slightly, while Aflac U.S. pretax adjusted earnings saw a marginal increase. The company maintained strong liquidity and capital positions, with substantial cash reserves and available credit facilities, and took steps to manage its capital allocation strategically.

Financial Statements
Beta
Revenue$5.16B
SG&A Expenses$779.00M
Operating Income$1.18B
Interest Expense$55.00M
Net Income$566.00M
EPS (Basic)$0.78
EPS (Diluted)$0.78
Shares Outstanding (Basic)724.37M
Shares Outstanding (Diluted)727.51M

Key Highlights

  • 1Net earnings decreased to $566 million from $928 million in Q1 2019, driven by higher net investment losses.
  • 2Total revenues decreased to $5.2 billion from $5.7 billion.
  • 3Total comprehensive income significantly decreased to a loss of $2,709 million from a gain of $3,258 million, largely due to a $4,605 million unrealized loss on fixed maturity securities.
  • 4Aflac Japan's pretax adjusted earnings increased by 2.5% to $855 million, while Aflac U.S.'s pretax adjusted earnings increased by 0.9% to $326 million.
  • 5The company repurchased 10.0 million shares of its common stock for $449 million during the quarter.
  • 6The company maintained strong liquidity, with $4.1 billion in cash and cash equivalents at quarter-end, and had no borrowings under its significant revolving credit facilities.
  • 7COVID-19's impact on sales was significant, with Aflac Japan sales down an estimated 65% and Aflac U.S. sales down an estimated 55% in April 2020 compared to the prior year.

Frequently Asked Questions